Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01276626

Study of Bacteria on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome

Pilot Study of Probiotic Bifidobacterium Longum (B. Longum) on Mood and Bowel Symptoms in Patients With Irritable Bowel Syndrome (IBS).

Sponsor: McMaster University

Conditions IBS Irritable Bowel Syndrome

Interventions Bifidobacterium longum Maltodextrin

Updated 7 times since 2017 Last updated: Aug 4, 2014 Started: Jan 31, 2011 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates IBS and Irritable Bowel Syndrome and is currently completed. McMaster University leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Mar 2023 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

McMaster University
Société des Produits Nestlé (SPN)

Data source: Société des Produits Nestlé (SPN)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada